Korro Bio, Inc. (KRRO )
Currency in USD Disclaimer
Subscribe Now for Delta3 AI Alerts
Don’t miss out on top stock picks and market insights. Subscribe to Delta3 AI Alerts for real-time updates and expert analysis straight to your inbox. Stay informed and maximize your investment potential.
Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
- Symbol KRRO
- Company Korro Bio, Inc.
- Price $11.8
- Changes Percentage -14.68
- Change -2.03
- Day Low $11.76
- Day High $14.36
- Year High $55.89
- Year Low $5.2
- Market Cap $131,185,377
- Price Avg 50 EMA (D) $12.54
- Price Avg 200 EMA (D) $11.85
- Exchange NASDAQ
- Volume 45,354
- Average Volume 187,025
- Open $14.18
- Previous Close $13.83
- EPS -10
- PE -1.32
- Earnings Announcement 2026-11-11 05:00:00
- Shares Outstanding $9,953,367
Company brief: KORRO BIO, INC. (KRRO )
- Healthcare
- Biotechnology
- Mr. Ram Aiyar MBA, Ph.D.
- https://www.korrobio.com
- US
- N/A
- 10-03-2019
- US5009461089
Korro Bio, Inc., a biopharmaceutical company, discovers, develops, and commercializes genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases. Korro Bio, Inc. is based in Cambridge, Massachusetts.